Setting Glutamine Concentration in Culture
The Ranges
| Context | Glutamine | Note |
|---|---|---|
| Plasma | 0.5–0.8 mM | The physiological reference |
| Standard DMEM/RPMI | 2–4 mM | Several-fold above plasma |
| "Low glutamine" protocols | 0.5–1 mM | Approximates plasma |
| Glutamine-free | 0 mM | Requires substitution and rescue design |
Important distinction. Most published glutamine-dependency work is performed at 2–4 mM, which is the concentration at which cells have the most alternative substrate available. A dependency at 4 mM is a stronger claim than one at 0.5 mM, but a negative result at 4 mM does not exclude a dependency at physiological concentrations.
Part 1 — Concentration Determines the Route
| Concentration | Dominant use | Consequence for inhibitors |
|---|---|---|
| High (4 mM) | Glutamate export, glutathione, nucleotide synthesis, signalling | GLS inhibition can be bypassed by glutamate import |
| Moderate (1–2 mM) | Balanced anaplerosis and nitrogen donation | Partial sensitivity to GLS inhibition |
| Low (0.5 mM) | Anaplerosis becomes limiting | Stronger sensitivity; dependency appears |
| Zero | Cells depend on synthesis or on other substrates | Not a physiological condition; requires rescue design |
Readout note. The same cell line can be "glutamine-independent" at 4 mM and "glutamine-dependent" at 0.5 mM. Both statements are true and neither generalises. The concentration belongs in the title of the experiment, not only in the methods.
Part 2 — Degradation and Ammonia
Glutamine degrades spontaneously in culture medium at 37 °C, and the product is ammonia.
| Factor | Effect |
|---|---|
| Temperature | Degradation accelerates with temperature |
| Time since preparation | Linear accumulation over days |
| Medium formulation | Higher glutamine means more ammonia |
| Vessel and headspace | Ammonia is volatile; open vessels lose it |
| pH | Affects the equilibrium and the assay |
Caveat on medium age. A medium prepared weekly and stored at 4 °C degrades more slowly than one kept at 37 °C, but neither is stable indefinitely. Ammonia accumulation of 1–2 mM over a culture interval is common with 4 mM glutamine and is enough to affect autophagy and mTORC1 signalling. Measuring ammonia at the end of the experiment is the only way to know whether it contributed.
Part 3 — Designing a Concentration Series
| Step | Design | What it establishes |
|---|---|---|
| 1 | 0, 0.25, 0.5, 1, 2, 4 mM | The concentration–response of growth |
| 2 | Ammonia at each concentration, matched timepoint | Whether ammonia confounds the low-glutamine arm |
| 3 | Osmolarity matched with an inert solute | Whether the effect is osmotic |
| 4 | Glutamate supplementation at low glutamine | Whether GLS bypass explains the phenotype |
| 5 | Rescue panel at the limiting concentration | Which role became limiting |
The second step is essential in a glutamine series, because low glutamine reduces ammonia while high glutamine raises it; without measuring it, the two effects are confounded in opposite directions.
The third step is often skipped: glutamine is a solute, and 4 mM versus 0 mM is a measurable osmolarity difference. An equimolar substitution — typically with sodium chloride or another amino acid — controls for it.
Part 4 — What a Concentration Effect Can Support
| Claim | Requires | Not sufficient |
|---|---|---|
| "The cells require glutamine" | A concentration–response with a limiting range | A single glutamine-free arm |
| "The dependency is anaplerotic" | α-KG or glutamate rescue at the limiting concentration | Growth difference alone |
| "GLS inhibition is effective" | CB-839 at two glutamine concentrations | A single concentration |
| "Ammonia is toxic at this concentration" | Ammonia measured, pH matched | Ammonia assumed |
| "The effect is physiological" | Concentrations near plasma | 4 mM conditions |
Part 5 — Common Failures
- • Concentration unstated or stated only as "standard medium".
- • Dependency generalised from 4 mM to physiological conditions.
- • Ammonia not measured in a low-glutamine comparison.
- • Osmolarity not matched across a concentration series.
- • Medium age unrecorded, so degradation is attributed to the cells.
- • Glutamine-free medium used without a rescue panel, so the limiting role is unknown.
- • Glutamate import unconsidered, although it can bypass GLS.
Part 6 — Where This Article Connects
This is the medium-design article for the amino acid cluster, and it sets the condition under which the glutaminolysis and CB-839 articles are interpretable. It connects to the urea and ammonia article for the product measurement, and to the serine-free medium article for the same set of dropout design issues.
If you need glutamine concentration series with matched osmolarity and ammonia measurement, we can scope the design with you.
Contact EDITGENE to request a project consultation or quote.
Scientific scope and validation note
Glutamine requirements, degradation rates and ammonia tolerance vary with cell type, medium formulation and handling. The ranges here are starting points.
A dependency at one concentration does not establish a dependency at another, and ammonia accumulation is a co-variable in any concentration series.
Scientific interpretation and experimental design
- • Culture is supraphysiological. State the concentration.
- • Concentration sets the route. Dependencies move with it.
- • Glutamine makes ammonia. Measure it.
- • Match osmolarity. Glutamine is a solute.
- • Medium age is a variable.
- • Rescue panel at the limiting concentration.
Selected references for further reading
- • DeBerardinis RJ, Cheng T. Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene. 2010;29:313–324.
- • Tritsch GL, Moore GE. Spontaneous decomposition of glutamine in cell culture media. Experimental Cell Research. 1962;28:360–364.
- • Hosios AM, et al. Amino acids rather than glucose account for the majority of cell mass in proliferating mammalian cells. Developmental Cell. 2016;36:540–549.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| PBRM1 Knockout A-549 Cell Line | EDJ0001-K01 | Human | 55193 | Details Get a Quote |
| YTHDC1 Knockout A-549 Cell Line | EDC07652 | Human | 91746 | Details Get a Quote |
| TP53 Knockout HCT 116 Cell Line | EDC07854 | Human | 7157 | Details Get a Quote |
| Sirt2 Knockout MH-S Cell Line | EDJ-KQ78173 | Mouse | 64383 | Details Get a Quote |
| TFE3 Knockout KGN Cell Line | EDJ-KQ48 | Human | 7030 | Details Get a Quote |
| Stub1 Knockout MB49 Cell Line | EDJ-KQ53 | Mouse | 56424 | Details Get a Quote |
| ARID1A Knockout SNK-6 Cell Line | EDJ-KQ64 | Human | 8289 | Details Get a Quote |
| Tet1 Knockout Kupffer Cell Line | EDJ-KQ88 | Mouse | 52463 | Details Get a Quote |
| NR1H3 Knockout HEK293T Cell Line | EDJ-KQ109 | Human | 10062 | Details Get a Quote |
| NR1H2 Knockout HEK293T Cell Line | EDJ-KQ110 | Human | 7376 | Details Get a Quote |
| RPS6KB2 Knockout HEK293 Cell Line | EDJ-KQ125 | Human | 6199 | Details Get a Quote |
| SMAD6 Knockout HEK293 Cell Line | EDJ-KQ126 | Human | 4091 | Details Get a Quote |
| JUN Knockout HEK293 Cell Line | EDJ-KQ176 | Human | 3725 | Details Get a Quote |
| JUN Knockout HEK293T Cell Line | EDJ-KQ184 | Human | 3725 | Details Get a Quote |
| ALKBH5 Knockout HEK293 Cell Line | EDJ-KQ186 | Human | 54890 | Details Get a Quote |
- 1
- 2
- ...
- Next Page »